Moshe Szyf, PhD, Founder
WORLD CLASS LEADERSHIP
-
McGill Professor Department of Pharmacology and Therapeutics at McGill University, Canada
-
Pioneer of the field of epigenetics Inventor of the first broad patents in the field
-
Inventor of first patents on DNA methylation and cancer
-
Founder of the field of behavioral and psychiatry epigenetics
-
Thought leader, published 255 papers in the area
-
Fellow of the Royal society of Canada
-
Fellow of the Canadian Academy of Health Sciences
-
McGill Professor Department of Pharmacology and Therapeutics at McGill University, Canada
-
Pioneer of the field of epigenetics Inventor of the first broad patents in the field
-
Inventor of first patents on DNA methylation and cancer
-
Founder of the field of behavioral and psychiatry epigenetics
-
Thought leader, published 255 papers in the area
-
Fellow of the Royal society of Canada
-
Fellow of the Canadian Academy of Health Sciences
A LEADING-EDGE FORCE IN THE EMERGING SCIENCE OF EPIGENETICS
-
With a Ph.D from the celebrated Hebrew University, a postdoctoral fellowship in Genetics at Harvard Medical School, a Professorship at McGill University and a Chair in Pharmacology at GlaxoSmithKline, Dr. Szyf is a “pioneer powerhouse” in the industry.
-
McGill ranks #1 in Canada, among medical-doctoral universities, and Szyf is keeping the best company among the Hebrew University’s first Board of Governors: Albert Einstein, Sigmund Freud and Chaim Weizman.
